Follow

Submissions from 2022

PDF

An Atypical Case of Extreme Polypharmacy, Michael A. Veronin

Submissions from 2021

PDF

Assessing potentiation of the (α4)3(β2)2 nicotinic acetylcholine receptor by the allosteric agonist CMPI, Farah Deba, Kemburli Munoz, Eloisa Peredia, Gustav Akk, and Ayman K. Hamouda

Submissions from 2020

PDF

Examining the Effects of (α4)3(β2)2 Nicotinic Acetylcholine Receptor-Selective Positive Allosteric Modulator on Acute Thermal Nociception in Rats, Farah Deba, Kara Ramos, Matthew Vannoy, Kemburli Munoz, Lois S. Akinola, M. Imad Damaj, and Ayman K. Hamouda

Submissions from 2019

PDF

Development of a Unique Student Pharmacist Internship in a Primary Care Provider System, Norman E. Fenn III, Natalie R. Gadbois, Gwen J. Seamon, Shannon L. Castek, and Kimberly S. Plake

Submissions from 2015

PDF

Pharmacologic Activities of 3’-Hydroxypterostilbene: Cytotoxic, Anti- Oxidant, Anti-Adipogenic, Anti-Inflammatory, Histone Deacetylase and Sirtuin 1 Inhibitory Activity, Jody K. Takemoto, Connie M. Remsberg, and Neal M. Davies